Recurrent carcinoma of the head and neck: Treatment strategies and survival analysis in a 20-year period

Oral Oncology

Volumn 40, Issue 4, 2004, Pages 427-432

  Eckardt, A ^a   Barth, E L ^a   Kokemueller, H ^a   Wegener, G ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Intraoperative frozen section; Recurrent head and neck cancer; Resection margin; Salvage surgery

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN;

ADULT; AGED; ARTICLE; CALCULATION; CANCER CLASSIFICATION; CANCER GROWTH; CANCER INCIDENCE; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; INTERMETHOD COMPARISON; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; PRIORITY JOURNAL; PROBABILITY; RECURRENT CANCER; RETROSPECTIVE STUDY; TIME;

EID: 1242338041     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2003.09.019     Document Type: Article

References (35)

1. Cooney T.R., Poulsen M.G. Is routine follow-up useful after combined modality therapy for advanced head neck cancer? Arch. Otolaryngol. Head Neck Surg. 125:1999;379-382.
2. Hemprich A., Müller R.P. Long-term results in treating squamous cell carcinoma of the lip, oral cavity, and oropharynx. Int. J. Oral Maxillofac. Surg. 18:1989;39-42.
3. Böttcher HD, Wendt TG, Henke M (Hrsg) Klinik des Rezidivtumors im Kopf-Hals-Bereich. München: Zuckschwerdt Verlag; 2001.
4. Olsen K.D., Caruso M., Foote R.L., Stanley R.J., Lewis J.E., Buskirk S.J.et al. Primary head and neck cancer - histopathologic predictors of recurrence after neck dissection in patients with lymph node involvement. Arch. Otolaryngol. Head Neck Surg. 120:1994;1370-1374.
5. Jones A.S., Bin Hanafi Z., Nadapalan V., Roland N.J., Kinsella A., Helliwell T.R. Do positive resection margins after ablative surgery for head and neck cancer adversely affect prognosis? A study of 352 patients with recurrent carcinoma following radiotherapy treated by salvage surgery. Br. J. Cancer. 74:1996;128-132.
6. Rodrigo J.P., Suarez C. Prognostic significance of postoperative wound infection on head and neck cancer. Otolaryngol. Head Neck Surg. 118:1998;272-275.
7. Brennan J.A., Mao L., Hruban R.H., Boyle J.O., Eby Y.J.et al. Molecular assessment of histopathological staging in squamous cell carcinoma of the head and neck. New Engl. J. Med. 332:1995;429-435.
8. Ganly I., Kaye S.B. Recurrent squamous-cell carcinoma of the head and neck: overview of current therapy and future prospects. Ann. Oncol. 11:2000;11-16.
9. Kokal W.A., Neifeld J.P., Eisert D.R., terz J.J., Lawrence W. Jr. Management of locoregional recurrent oropharyngeal carcinoma. Am. J. Surg. 146:1983;436-438.
10. Kaplan E.L., Meier P. Non parametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:1958;457-481.
11. Gonzales-Moles M.A., Esteban F., Rodriguez-Archilla A., Ruiz-Avilla I., Gonzales-Moles I. Importance of tumor thickness measurement in prognosis of tongue cancer. Oral Oncol. 38:2002;394-397.
12. Kowalski L.P., Magrin J., Waksman G., Santo G.F., Lopes M.E., de Paula R.P.et al. Supraomohyoid neck dissection in the treatment of head and neck tumors. Survival results in 212 cases. Arch. Otolaryngol. Head Neck Surg. 119:1993;958-963.
13. Leemans C.R., Tiwari R., Nauta J.J., van der Waal I., Snow G.B. Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor. Cancer. 73:1994;187-190.
14. Magnano M., Bussi M., De Stefani A., Milan F., Lerda W., Ferrero V.et al. Prognostic factors for head and neck tumor recurrence. Acta Otolaryngol. 115:1995;833-838.
15. Ramadan H.H., Wetmore S.J. Effect of wound infections on head and neck cancer. Arch. Otolaryngol. Head Neck Surg. 118:1992;486-487.
16. Janßen S. Das lokoregionäre Tumorrezidiv im Kopf-Hals-Bereich - Therapiestrategien und Überlebensanalyse im Zeitraum 1979 bis 1998 Med. Diss, Med. Hochschule Hannover, 2002.
17. Snow G.B. Evaluation and staging of the patient with head and neck cancer. 1989;Churchill Livingstone, New York.
18. Slootweg P.J., Hordijk G.J., Schade J., van Es R.J.J., Koole R. Treatment failure and margin status in head and neck cancer. A critical view on the potential value of molecular pathology. Oral Oncol. 38:2002;500-503.
19. Chen T.Y., Emrich L.J., Driscoll D.L. The clinical significance of pathological findings in surgically resected margins of the primary tumor in head and neck carcinoma. Int. J. Radiat Oncol. Biol. Phys. 13:1987;833-837.
20. Cook J.A., Jones A.S., Phillips D.E., Soler Lluch E. Implications of tumor in resection margins following surgical treatment of squamous cell carcinoma of the head and neck. Clin. Otolaryngol. 18:1993;37-41.
21. Ord R.A., Aisner S. Accuracy of frozen sections in assessing margins in oral cancer resection. J. Oral Maxillofac. Surg. 55:1987;663-669.
22. Ribeiro N.F.F., Godden D.R.P., Wilson G.E., Butterworth D.M., Woodwards R.T.M. Do frozen sections help achieve adequate surgical margins in the resection of oral carcinoma? Int. J. Oral Maxillofac. Surg. 32:2003;152-158.
23. Lee J.G. Detection of residual carcinoma of the oral cavity, oropharynx, hypopharynx and larynx: a study of surgical margins. Trans. Am. Acad. Ophthalmol. Otolaryngol. 78:1974;49-53.
24. Zieske A.L., Johnson J.T., Myers E.N., Thearle P.B. Squamous cell carcinoma with positive margins. Arch. Otolaryngol. Head Neck Surg. 112:1986;863-866.
25. Woolgar J.A., Scott J., Vaughan E.D., Brown J.S., West C.R., Rogers S. Survival, metastasis and recurrence of oral cancer in relation to pathological features. Ann. R. Coll. Surg. Engl. 77:1995;325-331.
26. Wong L.Y., Wei W.I., Lam L.K., Yuen A.P.W. Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery. Head Neck. 25:2003;953-959.
27. Ridge J.A. Squamous cancer of the head and neck: surgical treatment of local and regional recurrence. Sem. Oncol. 20:1993;419-429.
28. Goodwin W.J. Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means? Laryngoscope. 110:2000;1-18.
29. Tucker H.M., Rabuzzi D.D., Reed G.F. Massive surgery for palliation. Laryngoscope. 83:1973;1635-1643.
30. Koscielny S., Beleites E., Schumann D. Moderne Möglichkeiten der palliativen chirurgischen Therapien bei inkurablen Kopf-Hals-Tumoren. Onkologe. 8:2003;165-168.
31. Fontanesi J., Hetzler D., Ross J. Effect of dose rate of local control and complications in the reirradiation of head and neck tumors with interstitial iridium-192. Int. J. Radiat. Oncol. Biol. Phys. 17:1989;365-369.
32. Shaw H.J. Palliation in head and neck cancer. J. Laryngol. Otol. 99:1985;1131-1142.
33. Friedrich R.E., Krull A.et al. Salvage therapy of advanced squamous cell carcinoma of the mouth cavity and oropharynx. Results of interstitial high-dose-rate brachytherapy combined with ablative surgery. Strahlenther. Onkol. 173:1997;507-512.
34. Haas I., Hauser U., Ganzer U. The dilemma of follow-up in head and neck cancer patients. Eur. Arch. Otorhinolaryngol. 258:2001;177-183.
35. Stokkel M.P., Terhaard C.H., Hordijk G.J., van Rijk P.P. The detection of local recurrent head and neck cancer with fluorine-18-fluorodeoxyglucose dual head positron emission tomography. Eur. J. Nucl. Med. 26:1999;767-773.